Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia

Clinical Genetics

Volumn 66, Issue 6, 2004, Pages 556-561

  Brusgaard, Klaus ^a   Kjeldsen, A D ^a   Poulsen, L ^a   Moss, H ^a   Vase, P ^b   Rasmussen, K ^a   Kruse, T A ^a   Horder M ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b SVENDBORG HOSPITAL   (Denmark)

Author keywords

Activin receptor like kinase 1; Endoglin; HHT; Mutation detection

Indexed keywords

ACTIVIN RECEPTOR 1; ENDOGLIN;

ARTICLE; CAUCASIAN; CHROMOSOME 12Q; CHROMOSOME 9Q; CHROMOSOME MAP; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DENMARK; FAMILY STUDY; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC IDENTIFICATION; GENETIC SCREENING; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; SENSITIVITY ANALYSIS;

ACTIVIN RECEPTORS, TYPE I; ANTIGENS, CD; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 9; DENMARK; DNA MUTATIONAL ANALYSIS; ELECTROPHORESIS; FEMALE; GENETIC SCREENING; HUMANS; MALE; MUTATION; PEDIGREE; RECEPTORS, CELL SURFACE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; VASCULAR CELL ADHESION MOLECULE-1;

EID: 9444256275     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2004.00341.x     Document Type: Article

References (47)

1. Bideau A, Plauchu H, Brunet G, Robert JM. Etude épidémiologique de la meladie de Rendu Osler en France: répartition géographique et prevalence. Population 1989: 1: 9-28.
2. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Int Med 1999: 245: 31-39.
3. Porteous MEM, Curtis A, Williams O, Marchuk D, Bhattacharya SS, Burn J. Genetic heterrogeneity in hereditary haemorrhagic teleangiectasia. J Med Genet 1994: 31: 925-926.
4. McDonald MT, Papenberg KA, Ghosh S et al. A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9p33-34. Nat Genet 1994: 6: 197-204.
5. Shovlin CL, Hughes JM, Tuddenham EG et al. A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 1994: 6: 205-209.
6. MacAllister KA, Grogg KM, Johnson DW et al. Endoglin a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangictasia type 1. Nat Genet 1994: 8 (4): 345-351.
7. Johnson DW, Berg JN, Baldwin MA et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996: 13: 189-195.
8. Ten Dijke P, Yamashita H, Ichijo H et al. Characterization of type I receptors for transforming growth factor-beta and activin. Science 1994: 264 (5155): 101-104.
9. Yamashita H, Ichijo H, Grimsby S, Morén A, ten Dijke P, Miyazone K. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β. J Biol Chem 1994: 269 (3): 1995-2001.
10. Attisano L, Wrane JL. Signal transduction by members of the transforming growth factor-superfamily. Cytokine Growth Factor Rev 1996: 7 (4): 327-339.
11. Gallione CJ, Repetto GM, Legius E et al. A Combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004: 363: 852-859.
12. Kjeldsen A. Epidemiological and clinical aspects of hereditary haemorrhagic telangiectasia. Odense University: Thesis 1997 Mb. Osler.
13. Shovlin CL, Guttmacher AE, Buscarini E et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber Syndrome). Am J Med Genet 2000: 91: 66-67.
14. Kjeldsen AD, Møller T, Brusgaard K, Vase P, Andersen PE. Clinical symptoms according to genotype HHT1 and HHT2 in patients with hereditary haemorrhagic telangiectasia (HHT). J Med Genet 1994 (submitted).
15. Shovlin CL, Hughes JMB, Scott J, Seidman CE, Seidman JG. Characterization of endoglin and identification of noval mutations in hereditary haemorrhagic telangiectasia. Am J Genet 1997: 61: 68-79.
16. Rius C, Smith JD, Almendro N et al. Cloning of the promoter region of human endoglin, the target gene for hereditary haemorrhagic telangiectasia Type 1. Blood 1998: 92 (12): 4677-4690.
17. Lerman LS, Silverstein K. Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol 1987: 155: 482-501.
18. Fischer SG, Lerman LS. Separation of random fragments of DNA according to properties of their sequences. Proc Natl Acad Sci USA 1980: 77 (8): 4420-4424.
19. Den Dunnen JT, Paalman MH. Standardizing mutation nomenclature: why bother? Hum Mutat 2003: 22: 181-182.
20. Kwiatkowski DJ, Gusella JF. Dinucleotide repeat polymorphism at the D9S120 locus (9q31-34). Nucleic Acids Res 1992: 25 (20): 933.
21. Kwiatkowski DJ, Henske EP, Weimer K, Ozelius L, Gusella JF, Haines J. Construction of a GT polymorphism map of human 9q. Genomics 1992: 12 (2): 229-240.
22. Hudson TJ, Engelstein M, Lee KK et al. Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms. Genomics 1992: 13: 622-629.
23. Dib C, Fauré S, Fizames C et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996: 380: 152-154.
24. Lastelle P, Sabbà C, Lenato GM et al. Endoglin gene mutations and polymorphisms in Italian patients with hereditary haemorrhagic telangiectasia. Clin Genet 2003: 63: 536-540.
25. Cymerman U, Vera S, Karabegovic A, Abdalla S, Letarte M. Characterization of 17 novel endoglin mutations associated with hereditary haemorrhagic telangiectasia. Hum Mutat 2003: 21 (5): 482-492.
26. Risch N, de Leon D, Ozelius L et al. Genetic analysis of idiopathic torsion dystonia in Askenazi Jews and their recent descent from a smell founder population. Nat Genet 1995: 9: 152-159.
27. Berg JN, Guttmacher AE, Marchuk DA, Porteous ME. Clinical heterogenity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to Endoglin? J Med Genet 1996: 33: 256-257.
28. McAllister KA, Lennon F, Bowles BB et al. Genetic heterogeneity in hereditary haemorrhagic telangiectasia: possible correlation with clinical phenotype. J Med Genet 2003: 31: 927-932.
29. Berg J, Porteous M, Reinhardt D et al. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet 2003: 40 (8): 585-590.
30. Abdalla SA, Geisthoff UW, Bonneau D et al. Viceral manifestations in hereditary haemorrhagic telangiectasia type 2. J Med Genet 2003: 40: 494-502.
31. Pece N, Vera S, Cymerman U, White RI, Wrane JL, Letarte M. Mutant endoglin in hereditary haemorrhagic telangictasia type 1 is transiently expressed intercellularly and is not a dominant negative. J Clin Invest 1997: 100 (10): 2568-2579.
32. Gallione CJ, Klaus DJ, Yeh E et al. Mutation and expression analysis of the endoglin gene in hereditary haemorrhagic telangiectasia reveals null alleles. Hum Mutat 1998: 11 (4): 286-294.
33. MacAllister KA, Baldwin MA, Thukkani AK et al. Six novel mutations in the endoglin gene in hereditary haemorrhagic telangictasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet 1995: 4 (10): 1983-1985.
34. Yamaguchi H, Azuma H, Shigekiyo T, Inoue H, Saito S. A noval missense mutation in the endoglin gene in hereditary haemorrhagic telangictasia. Thromb Haemost 1997: 77 (2): 243-247.
35. Alberts MJ, Davis JP, Craffagnino C et al. Endoglin gene polymorphism as a risk factor for sporadic intercerebral hemorrhage. Ann Neurol 1997: 41 (5): 683-686.
36. McDonald MT, Papenberg KA, Ghosh S et al. A disease locus for hereditary haemorrhagic telangictasia maps to chromosome 9q33-34. Nat Genet 1994: 6: 197-204.
37. Dakeishi M, Shioya T, Wade Y et al. Genetic epidemiology of hereditary haemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 2002: 19: 140-148.
38. Lesca G, Plauchu H, Couler F et al. Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France. Hum Mutat 2004: 23: 289-299.
39. Berg JN, Gallione CJ, Stenzel TT et al. The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary haemorrhagic telangectasia type 2. Am J Genet 1997: 61: 60-67.
40. Klaus DJ, Gallione CJ, Anthony K. Novel missense and frameshift mutations in the activin receptor-like kinase-1 gene in hereditary haemorrhagic telangictasia. Hum Mutat (online) 1998: 164.
41. Kjeldsen A, Brusgaard K, Kruse T, Rasmussen K, Green A, Vase P. New mutations in the ALK1 gene and relation to the clinical manifestation of HHT in two large Danish families. Am J Med Genet 2001: 98 (4): 298-302.
42. Lin WD, Wu JY, Hsu HB, Tsai FJ, Lee CC, Tsai CH. Mutation analysis of a family with hereditary haemorrhagic telangiectasia associated with hepatic arteriovenous malformation. J Formos Med Assoc 2001: 100 (12): 817-819.
43. Trembath RC, Thomson JR, Machado RD et al. Clinical and molecular genetic features of pulomonary hypertension in patients with hereditary haemorrhagic telangiectasia. N Engl J Med 2001: 345: 325-334.
44. Abdalla SA, Cymerman U, Johnson RM, Deber CM, Letarte M. Disease-associated mutations in conserved residues of ALK-1 kinase domain. Eur J Hum Genet 2003: 11: 279-287.
45. Basher LH, Blake A, Byrd BR. An analysis of the pathologic anatomy of pulmonary arteriovenous aneurysms of local excision. Surgery 1959: 45: 91-104.
46. Lee DW, White RI Jr, Egglin TK et al. Embolotherapy of large pulmonary arteriovenous malformations: long-term results. Ann Thorac Surg 1997: 64: 930-940.
47. Gallione CJ, Scheessele EA, Reinhardt D et al. Two common endoglin mutations in families with hereditary haemorrhagic telangictasia in the Netherlands Antilles evidence for a founder effect. Hum Genet 2000: 107 (1): 40-44.